<DOC>
	<DOCNO>NCT03055819</DOCNO>
	<brief_summary>The LIFT study document first clinical use ZiftLift Tissue Anchor browlift patient age-related brow ptosis . It single arm , open label multicenter study , evaluate safety efficacy Zift Lift System . Up 20 subject 3 site enrol study . Data trial use confirm device safety efficacy provide input refine device design procedure technique future device iteration</brief_summary>
	<brief_title>Evaluation Patient Physician Satisfaction With Zift eLevatIon Facial Tissue Clinical Study</brief_title>
	<detailed_description>The LIFT study document first clinical use ZiftLift Tissue Anchor browlift patient age-related brow ptosis . It single arm , open label multicenter study , evaluate safety efficacy Zift Lift System . Up 20 subject 3 site enrol study . Data trial use confirm device safety efficacy provide input refine device design procedure technique future device iteration Subjects sign informed consent meet inclusion none exclusion criterion treat device consider enrol study . An interim report create first 20 patient complete 90 follow data monitor . The 20 patient , 90 day report may submit FDA agency product clearance registration . After FDA clearance obtain , study may convert post-market study long term follow .</detailed_description>
	<criteria>1 . Able provide inform consent treatment 2 . Willing able participate require followups 3 . Over 18 year age 4 . Under 75 year age 5 . Brow ptosis and/or functional limitation vision defect due tissue laxity cause age 1 . Known allergy local anesthesia 2 . Currently undergo chemotherapy radiation therapy cancer 3 . Known advanced osteoporosis may lead skull thin 4 . Taking longterm immunosuppressant therapy 5 . Taking chronic anticoagulation therapy ( include ASA NSAIDS ) ca n't stop 10 day treatment . 6 . Unable unwilling participate followup examination 7 . Evidence brow soft tissue thickness le 4mm physical exam , ultrasound direct probe ( probe time procedure ) 8 . Stroke TIE ( Transient Ischemic Event ) within past 6 month currently antiplatelet blood thinner 9 . Chronic facial paralysis due trauma , Bells Palsy , similar etiology 10 . Treatment neurotoxin past 6 month study period . Subjects may undergo neurotoxin washout 6 month prior study participation 11 . Planned surgical procedure , filler facial procedure study period . 12 . Planned modification eyebrow ( include pluck shave ) study period 13 . Planned MRI study period 14 . Known nickel allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Brow Lift</keyword>
	<keyword>Brow Ptosis</keyword>
</DOC>